Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 312

1.

Surgery in reference centers improves survival of sarcoma patients: a nationwide study.

Blay JY, Honoré C, Stoeckle E, Meeus P, Jafari M, Gouin F, Anract P, Ferron G, Rochwerger A, Ropars M, Carrere S, Marchal F, Sirveaux F, Di Marco A, Le Nail LR, Guiramand J, Vaz G, Machiavello JC, Marco O, Causeret S, Gimbergues P, Fiorenza F, Chaigneau L, Guillemin F, Guilloit JM, Dujardin F, Spano JP, Ruzic JC, Michot A, Soibinet P, Bompas E, Chevreau C, Duffaud F, Rios M, Perrin C, Firmin N, Bertucci F, Le Pechoux C, Le Loarer F, Collard O, Karanian-Philippe M, Brahmi M, Dufresne A, Dupré A, Ducimetière F, Giraud A, Pérol D, Toulmonde M, Ray-Coquard I, Italiano A, Le Cesne A, Penel N, Bonvalot S; NETSARC/REPPS/RESOS and French Sarcoma Group–Groupe d’Etude des Tumeurs Osseuses (GSF-GETO) Networks.

Ann Oncol. 2019 Apr 9. pii: mdz124. doi: 10.1093/annonc/mdz124. [Epub ahead of print]

PMID:
31081028
2.

Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling.

Di Benedetto P, Panzera N, Cipriani P, Mastroiaco V, Tessitore A, Liakouli V, Ruscitti P, Berardicurti O, Carubbi F, Guggino G, Bianchi A, Di Marco A, Ciccia F, Alesse E, Giacomelli R.

Sci Rep. 2019 May 9;9(1):7144. doi: 10.1038/s41598-019-43638-0.

3.

Conformity to Clinical Practice Guidelines at Initial Management in Adult Soft Tissue and Visceral Tumors since the Implementation of the NetSarc Network in Eastern France.

Gantzer J, Di Marco A, Fabacher T, Weingertner N, Delhorme JB, Brinkert D, Bierry G, Ghnassia JP, Jégu J, Kurtz JE.

Oncologist. 2019 May 9. pii: theoncologist.2018-0751. doi: 10.1634/theoncologist.2018-0751. [Epub ahead of print]

PMID:
31073021
4.

Improved Selective Class I HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides.

Bresciani A, Ontoria JM, Biancofiore I, Cellucci A, Ciammaichella A, Di Marco A, Ferrigno F, Francone A, Malancona S, Monteagudo E, Nizi E, Pace P, Ponzi S, Rossetti I, Veneziano M, Summa V, Harper S.

ACS Med Chem Lett. 2018 Nov 27;10(4):481-486. doi: 10.1021/acsmedchemlett.8b00517. eCollection 2019 Apr 11.

PMID:
30996783
5.

Epicardial Access for Ventricular Tachycardia Ablation: Experience With the Needle-in-needle Technique.

Anguera I, Aceña M, Moreno-Wiedmann Z, Dallaglio PD, Di Marco A, Rodríguez M.

Rev Esp Cardiol (Engl Ed). 2019 Apr 4. pii: S1885-5857(19)30072-6. doi: 10.1016/j.rec.2019.03.003. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
30956036
6.

Synthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery.

Borbély A, Figueras E, Martins A, Esposito S, Auciello G, Monteagudo E, Di Marco A, Summa V, Cordella P, Perego R, Kemker I, Frese M, Gallinari P, Steinkühler C, Sewald N.

Pharmaceutics. 2019 Apr 1;11(4). pii: E151. doi: 10.3390/pharmaceutics11040151.

7.

Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.

Di Marco A, Gonzalez Paz O, Fini I, Vignone D, Cellucci A, Battista MR, Auciello G, Orsatti L, Zini M, Monteagudo E, Khetarpal V, Rose M, Dominguez C, Herbst T, Toledo-Sherman L, Summa V, Muñoz-Sanjuán I.

Mol Pharm. 2019 May 6;16(5):2069-2082. doi: 10.1021/acs.molpharmaceut.9b00042. Epub 2019 Apr 4.

PMID:
30916978
8.

Design, Synthesis, and Biological Evaluation of New 1-(Aryl-1 H-pyrrolyl)(phenyl)methyl-1 H-imidazole Derivatives as Antiprotozoal Agents.

Saccoliti F, Madia VN, Tudino V, De Leo A, Pescatori L, Messore A, De Vita D, Scipione L, Brun R, Kaiser M, Mäser P, Calvet CM, Jennings GK, Podust LM, Pepe G, Cirilli R, Faggi C, Di Marco A, Battista MR, Summa V, Costi R, Di Santo R.

J Med Chem. 2019 Feb 14;62(3):1330-1347. doi: 10.1021/acs.jmedchem.8b01464. Epub 2019 Jan 23.

PMID:
30615444
9.

Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.

Ferrigno F, Biancofiore I, Malancona S, Ponzi S, Paonessa G, Graziani R, Bresciani A, Gennari N, Di Marco A, Kaiser M, Summa V, Harper S, Ontoria JM.

Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3689-3692. doi: 10.1016/j.bmcl.2018.10.028. Epub 2018 Oct 22.

PMID:
30482621
10.

Towards cardiac MRI based risk stratification in idiopathic dilated cardiomyopathy.

Brown PF, Miller C, Di Marco A, Schmitt M.

Heart. 2018 Oct 30. pii: heartjnl-2018-313767. doi: 10.1136/heartjnl-2018-313767. [Epub ahead of print] Review.

PMID:
30377260
11.

Asthma: Differential Diagnosis and Comorbidities.

Ullmann N, Mirra V, Di Marco A, Pavone M, Porcaro F, Negro V, Onofri A, Cutrera R.

Front Pediatr. 2018 Oct 3;6:276. doi: 10.3389/fped.2018.00276. eCollection 2018. Review.

12.

Ventricular Tachycardia Ablation Guided by Cardiac Magnetic Resonance.

Di Marco A, Claver E, Anguera I.

Rev Esp Cardiol (Engl Ed). 2019 May;72(5):418. doi: 10.1016/j.rec.2018.05.011. Epub 2018 Jun 6. English, Spanish. No abstract available.

PMID:
29884584
13.

Beta-blocker therapy is associated with a lower incidence of syncope due to fast ventricular tachycardias among implantable cardioverter-defibrillator patients with left ventricular dysfunction: results from a multicenter study.

Jiménez-Candil J, Anguera I, Durán O, Hernández J, Fernández-Portales J, Moríñigo JL, Martín A, Dallaglio P, Bravo L, di Marco A, Sánchez PL.

J Interv Card Electrophysiol. 2018 Jun;52(1):69-76. doi: 10.1007/s10840-018-0344-0. Epub 2018 Mar 20.

PMID:
29557531
14.

Late potentials abolition reduces ventricular tachycardia recurrence after ablation especially in higher-risk patients with a chronic total occlusion in an infarct-related artery.

Di Marco A, Oloriz Sanjuan T, Paglino G, Baratto F, Vergara P, Bisceglia C, Trevisi N, Sala S, Marzi A, Gulletta S, Cireddu M, Anguera I, Della Bella P.

J Cardiovasc Electrophysiol. 2018 Aug;29(8):1119-1124. doi: 10.1111/jce.13488. Epub 2018 Apr 10.

PMID:
29543365
15.

Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models.

Elbaum D, Beconi MG, Monteagudo E, Di Marco A, Quinton MS, Lyons KA, Vaino A, Harper S.

PLoS One. 2018 Mar 9;13(3):e0192028. doi: 10.1371/journal.pone.0192028. eCollection 2018.

16.

Next-generation sequencing: recent applications to the analysis of colorectal cancer.

Del Vecchio F, Mastroiaco V, Di Marco A, Compagnoni C, Capece D, Zazzeroni F, Capalbo C, Alesse E, Tessitore A.

J Transl Med. 2017 Dec 8;15(1):246. doi: 10.1186/s12967-017-1353-y. Review.

17.
18.

Chronic total occlusion in an infarct-related coronary artery and the risk of appropriate ICD therapies.

Di Marco A, Anguera I, Teruel L, Muntane G, Campbell NG, Fox DJ, Brown B, Skene C, Davidson N, Leon V, Dallaglio P, Elzein H, Garcia-Romero E, Gomez-Hospital JA, Cequier A.

J Cardiovasc Electrophysiol. 2017 Oct;28(10):1169-1178. doi: 10.1111/jce.13290. Epub 2017 Aug 4.

PMID:
28675508
19.

Exercise-Induced Bronchospasm and Allergy.

Caggiano S, Cutrera R, Di Marco A, Turchetta A.

Front Pediatr. 2017 Jun 8;5:131. doi: 10.3389/fped.2017.00131. eCollection 2017. Review.

20.

Cost-effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-colony stimulating factor for peripheral blood stem cell mobilization in multiple myeloma.

Milone G, Martino M, Leotta S, Spadaro A, Zammit V, Cupri A, Avola G, Camuglia MG, Di Marco A, Scalzulli P, Morelli M, Olivieri A, Tripepi G.

Leuk Lymphoma. 2018 Jan;59(1):42-48. doi: 10.1080/10428194.2017.1324161. Epub 2017 Jun 2.

PMID:
28573902

Supplemental Content

Loading ...
Support Center